Subcutaneous injection of IHP-102 prevents lung vaso-occlusion in sickle cell disease mice
Authors:
Open Access
- 19 October 2023
- journal article
- letter
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 109 (4) , 1259-1263
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Pathophysiology of Sickle Cell DiseaseAnnual Review of Pathology: Mechanisms of Disease, 2019
- Critical role of C5a in sickle cell diseaseAmerican Journal of Hematology, 2018
- Sickle cell diseaseNature Reviews Disease Primers, 2018
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell DiseaseNew England Journal of Medicine, 2017
- Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboliJCI Insight, 2017
- Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseCochrane Database of Systematic Reviews, 2015
- Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- A potent oral P‐selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell diseaseAmerican Journal of Hematology, 2012
- Sickle-cell diseaseThe Lancet, 2010
- Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activationNature Medicine, 2004